Stock comparison
Definium Therapeutics, Inc. is 1.7x more valuable than Regencell Bioscience Holdings Ltd by market capitalization ($5.21 B vs $3.01 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
DFTX is larger
Definium Therapeutics, Inc. is 1.7x more valuable than Regencell Bioscience Holdings Ltd by market capitalization ($5.21 B vs $3.01 B).
Market value leader
DFTX
Definium Therapeutics, Inc. is 1.7x more valuable than Regencell Bioscience Holdings Ltd by market capitalization ($5.21 B vs $3.01 B).
Profit leader
RGC
RGC: -$3.58M vs DFTX: -$183.79M.
| Metric | RGC | DFTX |
|---|---|---|
| Market cap | $3.01 B | $5.21 B |
| US-listed rank | #1824 | #1389 |
| Net income (latest FY) | -$3.58M | -$183.79M |
| Net margin | - | - |
| P/E (trailing FY) | - | - |
| SEC filings | 82 | 445 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Definium Therapeutics, Inc. is 1.7x more valuable than Regencell Bioscience Holdings Ltd by market capitalization ($5.21 B vs $3.01 B).
Full pages: Regencell Bioscience Holdings Ltd and Definium Therapeutics, Inc., or browse the full rankings.